Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Last 12 months price action with 12-month analyst target path
As of May 8, 2026, HealthEquity, Inc. (HQY) has a Wall Street consensus price target of $109.89, based on estimates from 27 covering analysts. With the stock currently trading at $83.99, this represents a potential upside of +30.8%. The company has a market capitalization of $7.14B.
Analyst price targets range from a low of $89.00 to a high of $125.00, representing a 33% spread in expectations. The median target of $110.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 25 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 1 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, HQY trades at a trailing P/E of 34.1x and forward P/E of 21.2x. The forward PEG ratio of 0.26 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +60.8% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonQuick answers to the most common questions about buying HQY stock.
The consensus Wall Street price target for HQY is $109.89, representing 30.8% upside from the current price of $83.99. With 27 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
HQY has a consensus rating of "Buy" based on 27 Wall Street analysts. The rating breakdown is predominantly bullish, with 25 Buy/Strong Buy ratings. The consensus 12-month price target of $109.89 implies 30.8% upside from current levels.
HQY trades at a forward P/E of 21.2316x, representing a moderate valuation. With analysts targeting $109.89 (30.8% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $125 for HQY, while the most conservative target is $89. The consensus of $109.89 represents the median expectation. These targets typically reflect 12-month expectations.
HQY is heavily covered by Wall Street, with 27 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 24 have Buy ratings, 1 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month HQY stock forecast based on 27 Wall Street analysts shows a consensus price target of $109.89, with estimates ranging from $89 (bear case) to $125 (bull case). The median consensus rating is "Buy".
HQY trades at a forward P/E ratio of 21.2x based on next-twelve-months earnings estimates compared to a trailing P/E of 34.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on HQY, with a "Buy" consensus rating and $109.89 price target (30.8% upside). 25 of 27 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
HQY analyst price targets range from $89 to $125, a 33% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $109.89 consensus represents the middle ground.